Here is where you'll find all the latest updates from The Eve Appeal; from research updates within the national media, to awareness and fundraising examples of our amazing supporters, both in national and regional media.
Stylist: This is why people are taking loud lipstick selfies on Instagram
An influx of selfies on your Instagram feed is hardly an unusual occurrence. But you’ll have probably spotted a higher incidence of snaps featuring women – and the odd man – sporting their best Stunna-sponsored pouts recently. And it’s all in aid of raising awareness for an issue that gets swept under the rug far too often. Gynaecological cancers.
Breaking taboos: Michelle Heaton on going through the menopause in her 30s…
The Liberty X singer and mum-of-two chose to have a mastectomy and hysterectomy after testing positive for the BRCA gene mutation - and encourages the nation to GET LIPPY about women's health and the importance of having open and honest conversations with loved ones.
Feel the cancer fear, check your body and speak up to break down taboos and save lives, says comedian Helen Lederer
Eve Appeal and Get Lippy campaign ambassador Helen Lederer is speaking out to raise awareness of ovarian, cervical, womb, vaginal and vulval cancers after losing close family members to other cancers in the past.
Helen is quoted as saying "You shouldn’t be embarrassed – that’s the big message and why I’m getting lippy today. Don’t be shy, it could cost you your life."
Get The Gloss: Caroline Hirons – “I’m desperate to change how we talk about our bodies”
Eve Appeal ambassador and skincare expert Caroline Hirons tells Get The Gloss why she’s championing our Get Lippy campaign, how a smear test could’ve made all the difference to her grandma and why it’s time we all got comfortable with talking about all things gynae-related
STELLA magazine: Why it’s time to talk about below-the-belt cancers
Every year, 21,000 women in the UK develop a gynaecological cancer. Yet it seems we’re still a nation too shy to speak up, with a fifth of women feeling unable to speak to their GP about their symptoms.
This is why women’s charity The Eve Appeal and the beauty industry’s Cosmetic Executive Women (CEW) have joined forces to launch Get Lippy. The campaign, which aims to raise awareness of gynaecological cancers, runs throughout May, and is backed by top beauty retailers such as Space NK, Harvey Nichols, Tesco and Oliver Bonas, and brands including Elemis, Vaseline, Hourglass, Eos, Lipstick Queen, Bali Balm and Smashbox.
Glamour Magazine: This is the important reason why women are sharing #GetLippy photos on social media
Women’s cancer charity, The Eve Appeal, is launching its #GetLippy campaign to encourage women and men to speak up and out about gynaecological health by sharing a ‘pout and shout’ selfie on social media.
The campaign is also calling on the UK to donate or purchase a lipstick from a #GetLippy beauty partner to help raise vital funds for Eve Appeal’s pioneering research, to save women’s lives through early detection, risk-prediction and prevention of all 5 gynaecological cancers.
More than 21,000 women are diagnosed with a form of gynaecological cancer each year in the UK and 21 women will die each day as a result. But only one in seven women can name a single type.
To break the taboos and raise awareness of signs and symptoms, The Eve Appeal is launching a new campaign called Get Lippy. And yes, that means ‘lippy’ in the sense of speaking up about all things gynae, but it also means lipstick! The Eve Appeal has partnered with national retailers, including Tesco, and beauty brands so you can buy a lipstick or lip balm and contribute to pioneering research for screening and interventions.
Channel 4 News: 80,000 cases of cancer in woman ‘preventable’ if gene mutation screenings were offered
Research which was funded by The Eve Appeal suggests that more than 80,000 cases of cancer could be prevented if ALL woman over the age of 30 were offered screening for gene mutations.
Woman carrying the ‘BRCA’ gene are much more likely to develop breast or ovarian cancer. Researchers in London have found that screening the entire population for the gene could also be more cost-effective.